RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
· restem
AI Briefing
- • RESTEM to present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30- July 1, 2026.
- • CEO Andres Isaias will participate in the conference as a keynote speaker.
- • RESTEM is a clinical-stage biotechnology company developing off-the-shelf cell therapies.
Source Summary
MIAMI, June 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, Andres Isaias, will participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference, taking place June 30 – July 1, 2026.
Advertisement